PRIA Logo™
117-hr-6980117th Congress

To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.

Sponsored By: Representative Hudson, Richard [R-NC-9]

Unknown

Summary

This bill requires the Food and Drug Administration to conduct a pilot program to increase the number of unannounced inspections of foreign drug manufacturing facilities and evaluate the differences between inspections of domestic and foreign facilities.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Hudson, Richard [R-NC-9]

NC • R

Cosponsors

  • Rep. Eshoo, Anna G. [D-CA-16]

    CA • D

    Sponsored 3/8/2022

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation